Table 1 Clinical features of lung adenocarcinoma cases subjected to LC-MS/MS

From: Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

Characteristic

(%)

Age (year)

 Median

65.0

 Range

32–78

Gender

 Male

19 cases (79.2%)

 Female

5 cases (20.8%)

Pathological stage

 IA

10 cases (41.7%)

 IB

14 cases (58.3%)

Presence of recurrence

 (+)

11 cases (45.8%)

 (−)

13 cases (54.2%)

PAC

 (+)

11 cases (45.8%)

 (−)

13 cases (54.2%)

  1. PAC=postoperative adjuvant chemotherapy with oral uracil–tegafur.
Back to article page